ALX Oncology Holdings Inc. ALXO
1.31
(0.05)
(3.68%)
as of 25 Sep
- Market cap
- $187.4M
- P/E
- 0.0×
Follow ALXO
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| P/E ratio | — | — | — | — |
+8 more quarters Free account |
| EV/Sales | — | — | — | — | |
| EV/FCF | — | — | — | — | |
| Quick Ratio | 9.36 | 6.95 | 1.82 | 2.19 | |
| Current Ratio | 9.71 | 7.21 | 2.07 | 2.40 | |
| Net Debt/EBITDA | 7.05 | 6.96 | 1.52 | 2.24 | |
| Debt/Assets | 6.03% | 4.77% | 16.51% | 12.22% | |
| Debt/Equity | 0.07 | 0.06 | 0.38 | 0.23 | |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating CF/Net income | 0.89 | 1.04 | 0.83 | 0.77 | |
| Capex/Depreciation | (0.14) | (2.63) | (1.32) | (9.33) | |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 | |
| Research and Development Expense of Revenue | 0.00% | 0.00% | 0.00% | 0.00% | |
| Selling, General and Administrative Expense of Revenue | 0.00% | 0.00% | 0.00% | 0.00% | |
| Intangible Assets out of Total Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Share Based Compensation of Revenue | 0.00% | 0.00% | 0.00% | 0.00% | |
| Free Cash Flow Yield | — | — | — | — | |
| Revenue per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating CF per Share | (0.12) | (0.18) | (0.35) | (0.32) | |
| Capex per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Free Cash Flow per Share | (0.12) | (0.18) | (0.35) | (0.32) | |
| Cash per Share | 1.02 | 1.34 | 0.83 | 1.13 | |
| Shareholders Equity per Share | 1.00 | 1.45 | 0.48 | 0.84 | |
| Interest Debt per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Book value per Share | 1.00 | 1.45 | 0.48 | 0.84 | |
| Free Cash Flow | (16.03) | (18.70) | (19.03) | (17.15) | |
| Working Capital | 128.68 | 125.39 | 26.17 | 38.79 | |
| Capital Expenditures | 0.03 | (0.05) | (0.05) | (0.06) | |
| Net Current Asset Value | 118.82 | 118.58 | 17.66 | 28.59 | |
| EV/EBIT | — | — | — | — | |
| Capex to Sales | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
| Average Payables | 3.96 | 3.90 | 4.71 | 7.24 | |
| Average Assets | 128.07 | 149.61 | 103.41 | 134.22 | |
| Average Common Equity | 100.30 | 119.82 | 69.80 | 90.80 |
Columns are period end dates